Find a Clinical Trial

The Project Every Child Protocol: A Registry, Eligibility, Screening, Biology and Outcome Study

A Phase 1/2, open-label, single dose study of SKY-GJB2 given as a single unilateral intracochlear administration in pediatric subjects with severe-to-profound GJB2-mediated hearing loss

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy

A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study